SCHEMBL7174757

SCHEMBL7174757

Cc1cc(C)c(PC(=O)c2c(Cl)cccc2Cl)c(C)c1.[LiH]

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
RAPGEF4 Q8WZA2 1/20 0.38
RAB9A P51151 2/20 0.37
TYK2 P29597 1/20 0.37
GAA P10253 3/20 0.37
POLB P06746 1/20 0.37
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
PBRM1 Q86U86 1/20 0.35
FABP3 P05413 1/20 0.35
FABP4 P15090 1/20 0.35
FEN1 P39748 1/20 0.34
HTT P42858 1/20 0.34
TSHR P16473 1/20 0.34
HDAC4 P56524 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7180118 0.95 TYK2 (0.40) ALDH1A1KMT2AMEN1RAPGEF4RAB9A
SCHEMBL7181202 0.90 CA12 (0.41) ALDH1A1KMT2AMEN1RAB9AGAA
SCHEMBL7182754 0.88 ALDH1A1 (0.45) ALDH1A1KMT2ARAB9ATYK2GAA
SCHEMBL7187603 0.86 L3MBTL1 (0.34) ALDH1A1KMT2AMEN1RAPGEF4LMNA
SCHEMBL7180019 0.86 RAB9A (0.41) ALDH1A1RAB9ATYK2GAAPOLB
SCHEMBL7180462 0.85 TYK2 (0.44) ALDH1A1KMT2ARAB9ATYK2FABP3
SCHEMBL7175063 0.83 KMT2A (0.35) ALDH1A1KMT2AMEN1RAPGEF4LMNA
SCHEMBL7188492 0.82 RAB9A (0.39) ALDH1A1RAB9ATYK2GAAPOLB
SCHEMBL7178138 0.82 ALDH1A1 (0.37) ALDH1A1KMT2AMEN1GAALMNA
SCHEMBL7185635 0.81 ALDH1A1 (0.39) ALDH1A1KMT2AMEN1RAB9ATYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 ALDH1A1 3416/4885KMT2A 1586/4885MEN1 2312/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 ALDH1A1 3984/4885KMT2A 956/4885MEN1 2263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.